ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000272829.1	ABT-263 (navitoclax)	Bladder urothelial carcinoma	0.04701697	Resistant
ENSG00000272829.1	ABT-263 (navitoclax)	Breast invasive carcinoma	0.009915435	Sensitive